Page 30 - 22-0424
P. 30

The International Journal of the Royal Society of Thailand
              Volume XI - 2019



              Somchai Bovornkitti is a fellow of the Royal Society of Thailand and an Emeritus
              Professor of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University.
              His qualifications are Bachelor of Medicine (1952), Doctor of Medicine (2002),

              DTM&H (University of Liverpool), Chest Diseases and Tuberculosis (University
              of Wales), MRCP (UK), FRCP, FRACP, and Hon FACP.  He was a Paediatric Chest
              Resident at Bellevue Hospital, New York University, in 1955-1956. His current
              interest is the environment health sciences and tropical diseases.


              References

              Ashley E, Dhorda M, Fairhurst R, Amaratunga C, Lim P, Suon S, et al. Spread
                      of artemisinin resistance in Plasmodium falciparum Malaria. N Engl J Med.
                      2014;371(5):411–423. doi:10.1056/nejmoa1314981.

              Chotivanich K and Hanboonkunupakarn B. Ivermectin for malaria control.
                      IJRST. 2018:X:15–30.
              Kobylinski KC, Jittamala P, Hanboonkunupakarn B, Pukrittayakamee S,

                      Pantuwatana K, Phasomkusolsil S, et al. Safety, pharmacokinetics, and
                      mosquito lethal effects of ivermectin in combination with dihydroartemisinin
                      piperaquine and primaquine in healthy adult Thai subjects. Clin Pharmacol
                      Ther. 2019;107(5):1221–1230. doi:10.1002/cpt.1716.
              MOPH, 2019. Thailand malaria elimination programme. Available from: http://
                      malaria. ddc.moph.go. th/malariaR10/index_v2.php.

              Phyo AP, Jittamala P, Nosten F, Pukrittayakamee S, Imwong M, White N, et al.
                      Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial
                      endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax

                      malaria: an open-label phase 2 trial. Lancet Infect Dis. 2016;16(1):61–69.
                      doi:10.1016/S1473-3099(15)00320-5.
              Pongvongsa T, Phommasone K, Adhikari B, Henriques G, Chotivanich K,
                      Hanboonkunupakarn B, et al. The dynamic of asymptomatic Plasmodium
                      falciparum  infections following  mass drug  administrations  with
                      dihydroarteminisin-piperaquine plus a single low dose of primaquine

                      in Savannakhet Province, Laos. Malar J. 2018;17:405. doi:10.1186/s12936-
                      018-2541-9.







              24                                   Precision Tools for Malaria Control and Mahidol University’s
                                                                    Research on the Malaria Elimination



                                                                                                  11/7/2565 BE   13:27
       _22-0424(011-026)3.indd   24
       _22-0424(011-026)3.indd   24                                                               11/7/2565 BE   13:27
   25   26   27   28   29   30   31   32   33   34   35